Skip to content

INOVIO PHARMACEUTICALS, INC.: 10-Q filed 2011-11-07

What INOVIO PHARMACEUTICALS, INC. reported in its quarterly report filed 2011-11-07 (fiscal Q3 2011): 34 published measures, 86 facts as tagged in accession 0001193125-11-298587.

This filing

Form
10-Q (quarterly report)
Filed
2011-11-07
Fiscal period
fiscal Q3 2011
Accession
0001193125-11-298587 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All INOVIO PHARMACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-09-3063,266,319USD
At 2010-12-3156,067,391USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2011-09-3011,962,364USD
At 2010-12-318,966,480USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-09-3050,745,239USD
At 2010-12-3146,502,993USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2011-09-3025,302,689USD
At 2010-12-3119,998,489USD
At 2010-09-3019,391,860USD
At 2009-12-3130,296,215USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-4,541,932USD92
2011-01-01 to 2011-09-30-9,776,704USD273
2010-07-01 to 2010-09-30-1,410,148USD92
2010-01-01 to 2010-09-30-11,320,272USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-01-01 to 2011-09-30-15,221,524USD273
2010-01-01 to 2010-09-30-8,589,579USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2011-01-01 to 2011-09-30113,964USD273
2010-01-01 to 2010-09-30156,482USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2011-07-01 to 2011-09-302,637,561USD92
2011-01-01 to 2011-09-308,162,589USD273
2010-07-01 to 2010-09-301,276,543USD92
2010-01-01 to 2010-09-303,784,791USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-01-01 to 2011-09-3024,322,402USD273
2010-01-01 to 2010-09-30-11,484,240USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-01-01 to 2011-09-30-3,793,087USD273
2010-01-01 to 2010-09-309,158,604USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2011-09-30-204,614,933USD
At 2010-12-31-194,838,229USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-09-30288,854USD
At 2010-12-31276,795USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2011-01-01 to 2011-09-301,431,976USD273
2010-01-01 to 2010-09-30974,107USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-6,336,451USD92
2011-01-01 to 2011-09-30-15,858,818USD273
2010-07-01 to 2010-09-30-4,556,518USD92
2010-01-01 to 2010-09-30-13,939,845USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-09-3032,733,707USD
At 2010-12-3122,877,207USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-09-309,703,601USD
At 2010-12-316,436,708USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2011-09-3010,113,371USD
At 2010-12-3110,113,371USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2011-09-30426,948USD
At 2010-12-3132,887USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2011-07-01 to 2011-09-308,974,012USD92
2011-01-01 to 2011-09-3024,021,407USD273
2010-07-01 to 2010-09-305,833,061USD92
2010-01-01 to 2010-09-3017,724,636USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2011-07-01 to 2011-09-306,987,824USD92
2011-01-01 to 2011-09-3015,873,601USD273
2010-07-01 to 2010-09-302,951,067USD92
2010-01-01 to 2010-09-308,764,891USD273

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2011-09-30255,238,121USD
At 2010-12-31241,233,334USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2011-09-30-5,206USD
At 2010-12-312,850USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2011-09-3051,303,955USD
At 2010-12-3147,100,911USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2011-09-309,773,176USD
At 2010-12-3111,180,002USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2011-09-30208,262USD
At 2010-12-31259,128USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2011-09-30817,598USD
At 2010-12-31178,328USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2011-09-30866,027USD
At 2010-12-31273,975USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-4,556,581USD92
2011-01-01 to 2011-09-30-9,815,906USD273
2010-07-01 to 2010-09-30-1,414,733USD92
2010-01-01 to 2010-09-30-11,329,317USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2011-07-01 to 2011-09-302,323,188USD92
2011-01-01 to 2011-09-308,734,806USD273
2010-07-01 to 2010-09-302,881,994USD92
2010-01-01 to 2010-09-308,959,745USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2011-01-01 to 2011-09-30101,905USD273
2010-01-01 to 2010-09-30143,308USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2011-01-01 to 2011-09-301,406,826USD273
2010-01-01 to 2010-09-301,439,017USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2011-07-01 to 2011-09-30346,970USD92
2011-01-01 to 2011-09-307,566,676USD273
2010-07-01 to 2010-09-30522,760USD92
2010-01-01 to 2010-09-302,226,932USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2011-01-01 to 2011-09-3024,309,472USD273
2010-01-01 to 2010-09-30548,621USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-09-30394,061USD273
2010-01-01 to 2010-09-30-80,552USD273

Inspect the source

Entity
INOVIO PHARMACEUTICALS, INC. / CIK 0001055726
Captured
2026-09-20T05:17:43.559Z
SEC response SHA-256
9bfa830827e08b2d190e6d0b4ce0274a3c0d8852b6e536b16b5cfeadcaa54cf9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001055726.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))